Daiichi Sankyo Announces New Strategic Immuno-Oncology Research Collaboration with AgonOx
Daiichi Sankyo Company, Limited announced that it has entered into a strategic collaboration with AgonOx,...
Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, announced that it...
FDA Approves Janssen’s STELARA for Treatment of Adults With Moderately to Severely Active Crohn’s...
Janssen Biotech Inc announced that the U.S. FDA has approved STELARA® (ustekinumab) for the treatment...
Alcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience
Alcon, the global leader in eye care and a division of Novartis, launches the NGENUITY®...
GSK announces positive real-world data for meningitis B vaccine in first year since UK...
Preliminary data from the world’s first national meningitis B immunisation programme with Bexsero1, launched one...
Dr. Reddy’s Laboratories announces the launch of Bupropion HCl Extended-Release Tablets
Dr. Reddy’s Laboratories Ltd announced that it has launched Bupropion HCl extended-release tablets, USP (SR)...
AstraZeneca enters commercialisation agreement with Aspen for anaesthetics portfolio
AstraZeneca announced that it has completed the commercialisation agreement with Aspen Global Incorporated (AGI), part...
TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos Científicos for the Latin American Market
TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos...
Janssen Submits Application to U.S. FDA to Expand Indication for Daratumumab
Janssen Biotech, Inc. announced a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been...
Agilent Chooses Colorado for New Pharma Manufacturing Facility
Agilent Technologies reports that it acquired 20 acres in Weld County in northern Colorado, on...
